4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
PharmaCyte Biotech, Inc. (PMCB) operates in the Biotechnology industry and is headquartered in Las Vegas, United States with about 2 employees. Its market capitalization is roughly $8 million. In the fiscal year ended 2025-04-30, PMCB reported $0M in revenue and $31M in net income.
PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States.
Interactive charts & full statements →
| Income statement | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($4M) | ($6M) | ($6M) | ($4M) |
| Net Income | $31M | $0M | ($4M) | ($4M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($2M) | ($1M) | ($1M) | ($1M) | ($1M) | — |
| Net Income | $1M | ($7M) | ($8M) | $12M | ($3M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| Total Assets | $55M | $60M | $73M | $91M |
| Total Liabilities | $3M | $20M | $1M | $1M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PMCB viewer.
About TickerBase · Data methodology & sources